根治性膀胱切除原位新膀胱术后代谢并发症及处理研究进展  

A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy

作　　者：董昊楠 王海峰 黄应龙[1] 施鸿金 毛岚 刘毅杰 王剑松[1] DONG Haonan;WANG Haifeng;HUANG Yinglong;SHI Hongjin;MAO Lan;LIU Yijie;WANG Jiansong(Dept.of Urology,The 2nd Affiliate Hospital of Kunming Medical University,Yunnan Institute of Urology,Kunming Yunnan 650101,China)

机构地区：[1]昆明医科大学第二附属医院泌尿外科,云南省泌尿外科研究所,云南昆明650101

出　　处：《昆明医科大学学报》2022年第12期159-163,共5页Journal of Kunming Medical University

基　　金：国家自然科学基金资助项目(82060464);云南省科技厅科技计划基金资助项目(202001AY070001-163)。

摘　　要：膀胱癌是泌尿系常见的恶性肿瘤之一,可分为非肌层浸润性膀胱癌以及肌层浸润性膀胱癌。根治性膀胱切除术是肌层浸润性膀胱癌的首选治疗方案;原位新膀胱术目前已经成为根治性膀胱切除术后首选的尿流改道方式,因术中需使用不同肠段,术后可能出现不同的代谢相关并发症,这些并发症也成为降低患者术后生活质量的原因之一。现对原位新膀胱术后代谢并发症的主要类型以及处理进展进行综述。Bladder cancer is one of the common malignant tumors of urinary system,which can be divided into two categoties,non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.Radical cystectomy is the treatment of choice for muscle-invasive bladder cancer.At present,orthotopic neobasical bladder surgery has become the preferred method of urinary diversion after radical cystectomy.Due to the use of different intestinal segments during surgery,different metabolic complications may occur after surgery,which also become one of the reasons for reducing the quality of life of patients after surgery.This article reviews the main types and management progress of metabolic complications after orthotopic neobasical bladder surgery.

关 键 词：膀胱癌 根治性膀胱全切术 原位尿流改道 代谢并发症 

分 类 号：R737.14[医药卫生—肿瘤]